Abbott Laboratories’ stock took a direct hit, wiping out nearly 10% of its market value following its Q4 earnings. Response? The CEO bought $2 million shares. Robert B. Ford, CEO of Abbott ...
One note, Abbott CEO Robert Ford specifically cited momentum into 2026 in his commentary. “Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results